Development of a Dietetic Pathway for Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)

The ASPH Dietetics team identified that only 22% of patients with MASLD were receiving dietetic input. The team worked with consultant and clinical nurse specialist colleagues to develop a referral pathway and increased this to 62%. The team are continuing to develop the pathway and audit the effectiveness of their input. Read the full poster below.